Latest News

Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Modified stem cells offer potential pathway to treat Alzheimer's disease

  • Scientists explain how memories stick together

  • In old age, lack of emotion, interest may signal brain is shrinking

  • Book early, after work if you want to enjoy your next hotel stay

  • Intravenously administered ketamine shown to reduce symptoms of chronic post-traumatic stress disorder

  • Distracted driving among teens threatens public health and safety

  • Conceptual representation in the brain: Towards mind-reading?

  • Common links between neurodegenerative diseases identified

  • For resetting circadian rhythms, neural cooperation is key

  • Neurons in brain tune into different frequencies for different spatial memory tasks

  •